InSphero and Physicians Committee launch HUMAIN Award 2025

Schlieren ZH/Washington – The Schlieren-based biotech company InSphero and the Physicians Committee for Responsible Medicine are offering the Human Advanced In Vitro Model Initiative (HUMAIN) Award for the second time. It recognizes non-animal approaches to in vitro research in human medicine.

(CONNECT) InSphero and the Physicians Committee invite researchers working on in-vitro technology to the second edition of their HUMAIN Award. According to the announcement, this award recognizes researchers who are committed to improving access to human medical and animal-free approaches in in-vitro research and whose work promotes their faster introduction.

Five winning laboratories will receive shopping vouchers worth 20,000 dollars each. InSphero technologies such as Akura Spheroid Microplates, Akura Organ-on-Chip Technology, 3D InSight Microtissues and ARCTis Cryo Microtissues or services from InSphero such as 3D InSight Services can be purchased for this purpose.

The winners will also receive access to a one-day seminar at InSphero's headquarters in Schlieren. There, 3D cell culture experts will provide comprehensive hands-on training with the proprietary scalable and reproducible 3D in vitro tools. There is also a travel allowance of up to 1000 dollars.

In addition, the winning teams receive two hours of advice per month from InSphero experts. In addition, up to 2,000 dollars are available for travel expenses for the presentation of their results at scientific conferences and 2,500 dollars for open access publication fees.

Non-profit, educational and research institutions can apply until July 14. The twelve-month project phase begins in October 2025.

InSphero is a spin-off of the University of Zurich and the Swiss Federal Institute of Technology Zurich and is based in the Bio-Technopark Schlieren-Zurich.ce/mm

View full article